RI
RTW Investments, LP cut its CADL stake below 5%
RTW Investments, LP reported owning 4.2% of Candel Therapeutics, Inc. (CADL) (3,211,008 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G